More evidence against alcohol or smoking in patients with unruptured intracranial aneurysm
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Intracranial aneurysms are common, with a prevalence of 3% in the general population.1 The growing availability of brain imaging has increased the number of incidentally discovered aneurysms. Rupture of intracranial aneurysms and the resulting subarachnoid hemorrhage (SAH) has a high case fatality and morbidity, and occurs at a relatively young age compared with other types of stroke.2 As yet, we do not have a medical treatment to prevent intracranial aneurysm formation and its subsequent rupture. Our only preventive treatments for existing aneurysms consist of invasive surgery or endovascular treatment, each with inherent risk of complications including death or permanent disability.3 The risks of treatment have to be balanced carefully against the risk of rupture.4 Consequently, an important recent focus of aneurysm research has been the identification of risk factors of aneurysmal rupture. Recently, a meta-analysis of 6 prospective cohort studies showed that prognostic factors for aneurysm rupture include age, hypertension, history of SAH, aneurysm size, aneurysm location, and Finnish or Japanese descent.5 Other factors might also predict aneurysm rupture, including smoking6 and family history of SAH.7
Footnotes
Go to Neurology.org for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the editorial.
See page 456
- © 2015 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Babak Hooshmand and Dr. David Smith
► Watch
Related Articles
Topics Discussed
Alert Me
Recommended articles
-
Article
Risk factors for all-cause death after diagnosis of unruptured intracranial aneurysmsSeppo Juvela, Hanna Lehto et al.Neurology, January 07, 2015 -
Clinical and Ethical Challenges
Management of unruptured intracranial aneurysmsLindsy N. Williams, Robert D. Brown, Jr et al.Neurology: Clinical Practice, April 15, 2013 -
Article
Association of intracranial aneurysm rupture with smoking duration, intensity, and cessationAnil Can, Victor M. Castro, Yildirim H. Ozdemir et al.Neurology, August 30, 2017 -
Article
ELAPSS score for prediction of risk of growth of unruptured intracranial aneurysmsDaan Backes, Gabriel J.E. Rinkel, Jacoba P. Greving et al.Neurology, March 31, 2017